Milestone Pharmaceuticals Inc. — Director's Dealing 2019

May 8, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2019-05-08

Reporting Person: Novo Holdings A/S (10% Owner, SEE REMARKS)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
CLASS C PREFERRED SHARES	$0.00		COMMON SHARES (1377048)		Direct
CLASS D PREFERRED SHARES	$0.00		COMMON SHARES (964089)		Direct

Footnotes

F1: Each Class C Preferred share and Class D Preferred share will automatically convert into one Common share upon the completion of the initial public offering.